Recurrent Breast Cancer Completed Phase 1 / 2 Trials for Doxorubicin (DB00997)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00182767Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian CancerTreatment
NCT00331552Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast CancerTreatment